T-Neuro Pharma is developing a diagnostic/therapeutic for Alzheimer’s Disease.
We have identified abnormal T-cells that enter the brain, attack neurons, and cause Alzheimer’s. These T-cells can be detected in blood, identifying an Alzheimer's patient early. This is the basis of our T-Track Diagnostic. These T-cells can be blocked from entering the brain, preventing the progression of Alzheimer’s. This is the basis of our T-Treat therapeutic.